BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts 2009;2:26-35. [PMID: 20054201 DOI: 10.1159/000194971] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Schmandt RE, Iglesias DA, Co NN, Lu KH. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 2011;205:518-25. [PMID: 21802066 DOI: 10.1016/j.ajog.2011.05.042] [Cited by in Crossref: 136] [Cited by in F6Publishing: 111] [Article Influence: 12.4] [Reference Citation Analysis]
2 de Groot PCM, Dekkers OM, Romijn JA, Dieben SWM, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reproduction Update 2011;17:495-500. [DOI: 10.1093/humupd/dmr001] [Cited by in Crossref: 196] [Cited by in F6Publishing: 169] [Article Influence: 17.8] [Reference Citation Analysis]
3 Barber TM, Franks S. The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today? Womens Health (Lond) 2012;8:147-54. [PMID: 22375718 DOI: 10.2217/whe.11.94] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
4 Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Gynecol Endocrinol 2016;32:38-41. [PMID: 26291816 DOI: 10.3109/09513590.2015.1075501] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
5 Melo AS, Bettiol H, Silva AA, Rosa-e-Silva AC, Cardoso VC, Reis RM, Ferriani RA, Barbieri MA, Vieira CS. Small for gestational age babies are not related to changes in markers of adipose tissue dysfunction during reproductive age. Early Hum Dev 2014;90:231-5. [PMID: 24602474 DOI: 10.1016/j.earlhumdev.2014.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 . Current Opinion in Endocrinology, Diabetes & Obesity. Current world literature. Curr Opin Endocrinol Diabetes Obes 2010;17:293-312. [PMID: 20418721 DOI: 10.1097/MED.0b013e328339f31e] [Reference Citation Analysis]
7 Verrotti A, D'Egidio C, Mohn A, Coppola G, Parisi P, Chiarelli F. Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 2011;52:199-211. [PMID: 21204821 DOI: 10.1111/j.1528-1167.2010.02897.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
8 Thong EP, Milat F, Joham AE, Mishra GD, Teede H. Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population‐based study. Clin Endocrinol 2020;93:564-71. [DOI: 10.1111/cen.14281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Abdel-mottaleb Y, Ali HS, El-kherbetawy MK, Elkazzaz AY, Elsayed MH, Elshormilisy A, Eltrawy AH, Abed SY, Alshahrani AM, Hashish AA, Alamri ES, Zaitone SA. Saponin-rich extract of Tribulus terrestris alleviates systemic inflammation and insulin resistance in dietary obese female rats: Impact on adipokine/hormonal disturbances. Biomedicine & Pharmacotherapy 2022;147:112639. [DOI: 10.1016/j.biopha.2022.112639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Choudhary N, Choudhary S, Kumar A, Singh V. Deciphering the multi-scale mechanisms of Tephrosia purpurea against polycystic ovarian syndrome (PCOS) and its major psychiatric comorbidities: Studies from network pharmacological perspective. Gene 2021;773:145385. [PMID: 33383117 DOI: 10.1016/j.gene.2020.145385] [Reference Citation Analysis]
11 Tsai YH, Wang TW, Wei HJ, Hsu CY, Ho HJ, Chen WH, Young R, Liaw CM, Chao JC. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility. Br J Nutr 2013;109:2190-8. [PMID: 23046530 DOI: 10.1017/S0007114512004369] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
12 Hakim C, Padmanabhan V, Vyas AK. Gestational Hyperandrogenism in Developmental Programming. Endocrinology 2017;158:199-212. [PMID: 27967205 DOI: 10.1210/en.2016-1801] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
13 Hoang V, Bi J, Mohankumar SM, Vyas AK. Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome. PLoS One 2015;10:e0126119. [PMID: 26010091 DOI: 10.1371/journal.pone.0126119] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
14 Chen Z, Shi Y. Polycystic ovary syndrome. Front Med China 2010;4:280-4. [DOI: 10.1007/s11684-010-0098-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
15 Arnon L, Hazut N, Tabachnik T, Weller A, Koren L. Maternal testosterone and reproductive outcome in a rat model of obesity. Theriogenology 2016;86:1042-7. [PMID: 27125699 DOI: 10.1016/j.theriogenology.2016.03.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
16 Graves BW. The Obesity Epidemic: Scope of the Problem and Management Strategies. Journal of Midwifery & Women's Health 2010;55:568-78. [DOI: 10.1016/j.jmwh.2010.05.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
17 Angelidis G, Dafopoulos K, Messini CI, Valotassiou V, Georgoulias P, Messinis IE. Ghrelin: New Insights into Female Reproductive System–Associated Disorders and Pregnancy. Reprod Sci 2012;19:903-10. [DOI: 10.1177/1933719112443880] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
18 de Melo AS, Dos Reis RM, Ferriani RA, Vieira CS. Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits. Open Access J Contracept 2017;8:13-23. [PMID: 29386951 DOI: 10.2147/OAJC.S85543] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
19 Bedrick BS, Eskew AM, Chavarro JE, Jungheim ES. Self-Administered Questionnaire to Screen for Polycystic Ovarian Syndrome. Womens Health Rep (New Rochelle) 2020;1:566-73. [PMID: 33786523 DOI: 10.1089/whr.2020.0073] [Reference Citation Analysis]
20 Rojas J, Chávez-Castillo M, Bermúdez V. The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus. Int J Reprod Med 2014;2014:797681. [PMID: 25763406 DOI: 10.1155/2014/797681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
21 Kim SH, Yoon JT. Morphological changes in mouse ovary due to hormonal hypersecretion and matrix metalloproteinase -2 activity. Histol Histopathol 2021;36:527-34. [PMID: 33620082 DOI: 10.14670/HH-18-318] [Reference Citation Analysis]
22 Pkhaladze L, Barbakadze L, Kvashilava N. Myo-Inositol in the Treatment of Teenagers Affected by PCOS. Int J Endocrinol 2016;2016:1473612. [PMID: 27635134 DOI: 10.1155/2016/1473612] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
23 Seyyed Anvari S, Dehgan GH, Razi M. Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome. Cell J 2019;21:243-52. [PMID: 31210429 DOI: 10.22074/cellj.2019.5952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Cornier M, Marshall JA, Hill JO, Maahs DM, Eckel RH. Prevention of Overweight/Obesity as a Strategy to Optimize Cardiovascular Health. Circulation 2011;124:840-50. [DOI: 10.1161/circulationaha.110.968461] [Cited by in Crossref: 46] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
25 Rosta K, Ott J, Kelemen F, Temsch W, Lahner T, Reischer T, Helmer H, Somogyi A. Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case-control study. Arch Gynecol Obstet 2018;298:1079-84. [PMID: 30225687 DOI: 10.1007/s00404-018-4895-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Vrbikova J. Polycystic ovary syndrome: why there is no cure. Expert Rev Endocrinol Metab 2012;7:475-7. [PMID: 30780894 DOI: 10.1586/eem.12.41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Marasco LA. Unsolved Mysteries of the Human Mammary Gland: Defining and Redefining the Critical Questions from the Lactation Consultant’s Perspective. J Mammary Gland Biol Neoplasia 2014;19:271-88. [DOI: 10.1007/s10911-015-9330-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
28 Lepine S, Jo J, Metwally M, Cheong YC. Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2017;11:CD009526. [PMID: 29125183 DOI: 10.1002/14651858.CD009526.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Aydin S, Aydin S. Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome. Biotechnic & Histochemistry 2013;89:98-103. [DOI: 10.3109/10520295.2013.821167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
30 Han C, Lei X, Yan P, Li X, Morrison ER. Age differences in preferences for body physique. Personality and Individual Differences 2021;181:111033. [DOI: 10.1016/j.paid.2021.111033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Vartanyan EV, Tsaturova KA, Devyatova EA, Mikhaylyukova AS, Levin VA, Petuhova NL, Markin AV, Steptsova EM. Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization. Gynecol Endocrinol 2017;33:8-11. [PMID: 29264980 DOI: 10.1080/09513590.2017.1399699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
32 Hepsen S, Cakal E, Karakose M, Eyerci N, Saat H, Beysel S, Oztekin S, Pinarli F, Parlak M. Melanocortin 3 receptor gene polymorphism is associated with polycystic ovary syndrome in Turkish population. Gynecol Endocrinol 2019;35:685-90. [PMID: 30784330 DOI: 10.1080/09513590.2019.1576614] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Costa EC, Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD. [Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome]. Arq Bras Endocrinol Metabol 2010;54:630-5. [PMID: 21085768 DOI: 10.1590/s0004-27302010000700007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
34 Ciaraldi TP, Aroda V, Mudaliar SR, Henry RR. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: Effects of pioglitazone and metformin treatment. Metabolism 2013;62:1587-96. [DOI: 10.1016/j.metabol.2013.07.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
35 Vrbíková J, Zamrazilová H, Sedláčková B, Šnajderová M. Metabolic syndrome in adolescents with polycystic ovary syndrome. Gynecological Endocrinology 2010;27:820-2. [DOI: 10.3109/09513590.2010.508851] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
36 Beydoun HA, Hossain S, Beydoun MA, Weiss J, Zonderman AB, Eid SM. Anti-Müllerian Hormone Levels and Cardiometabolic Disturbances by Weight Status Among Men in the 1999 to 2004 National Health and Nutrition Examination Survey. J Endocr Soc 2019;3:921-36. [PMID: 31020056 DOI: 10.1210/js.2018-00414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Türkçüoğlu I, Kafkasli A, Meydanli MM, Ozyalin F, Taşkapan C. Independent predictors of cardiovascular risk in polycystic ovarian syndrome. Gynecol Endocrinol 2011;27:915-9. [PMID: 21294689 DOI: 10.3109/09513590.2010.551566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
38 Orbetzova MM, Pehlivanov BK, Mitkov MM, Atanassova IB, Kamenov ZA, Kolarov GB, Genchev GD. Effect of short-term standard therapeutic regimens on neuropeptide Y and adipose tissue hormones in overweight insulin-resistant women with polycystic ovary syndrome. Folia Med (Plovdiv) 2011;53:15-24. [PMID: 22359978 DOI: 10.2478/v10153-011-0052-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
39 Beydoun HA, Beydoun MA, Hossain S, Stadtmauer L, Eid SM, Zonderman AB. Patterns of Bariatric Surgeries Among U.S. Women Diagnosed with Polycystic Ovarian Syndrome. J Womens Health (Larchmt) 2020;29:585-95. [PMID: 32077783 DOI: 10.1089/jwh.2019.7947] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhuang J, Wang X, Xu L, Wu T, Kang D. Antidepressants for polycystic ovary syndrome. Cochrane Database Syst Rev 2013;:CD008575. [PMID: 23728677 DOI: 10.1002/14651858.CD008575.pub2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 van den Akker OBA. For your eyes only: Bio-behavioural and psycho-social research priorities. Human Fertility 2013;16:89-93. [DOI: 10.3109/14647273.2013.779391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Sayyah-Melli M, Alizadeh M, Pourafkary N, Ouladsahebmadarek E, Jafari-Shobeiri M, Abbassi J, Kazemi-Shishvan MA, Sedaghat K. Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study. J Caring Sci 2015;4:225-31. [PMID: 26464839 DOI: 10.15171/jcs.2015.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
43 Beydoun HA, Beydoun MA, Wiggins N, Stadtmauer L. Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States. Maturitas 2012;71:55-61. [PMID: 22088801 DOI: 10.1016/j.maturitas.2011.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
44 Genazzani AD, Prati A, Despini G, Marini G, Ricchieri F. PCOS from Lifestyle to the Use of Inositol and Insulin Sensitizers. In: Genazzani AR, Brincat M, editors. Frontiers in Gynecological Endocrinology. Cham: Springer International Publishing; 2014. pp. 59-67. [DOI: 10.1007/978-3-319-03494-2_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Yuan C, Huang WQ, Guo JH, Liu XY, Yang JZ, Chen JJ, Wu Y, Ruan YC, Liu JY, Cui YG, Diao FY, Chan HC. Involvement of Kisspeptin in androgen-induced hypothalamic endoplasmic reticulum stress and its rescuing effect in PCOS rats. Biochim Biophys Acta Mol Basis Dis 2021;:166242. [PMID: 34389474 DOI: 10.1016/j.bbadis.2021.166242] [Reference Citation Analysis]
46 Schlienger JL. [Radical complications of obesity]. Presse Med 2010;39:913-20. [PMID: 20619595 DOI: 10.1016/j.lpm.2010.04.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
47 De Frène V, Verhofstadt L, Lammertyn J, Stuyver I, Buysse A, De Sutter P. Quality of Life and Body Mass Index in Overweight Adult Women with Polycystic Ovary Syndrome During a Lifestyle Modification Program. Journal of Obstetric, Gynecologic & Neonatal Nursing 2015;44:587-99. [DOI: 10.1111/1552-6909.12739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Kaul A, Sharma J. Impact of bariatric surgery on comorbidities. Surg Clin North Am. 2011;91:1295-312, ix. [PMID: 22054155 DOI: 10.1016/j.suc.2011.08.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
49 Wallace KL, Johnson V, Sopelak V, Hines R. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertil Steril 2011;96:1051-6. [PMID: 21851939 DOI: 10.1016/j.fertnstert.2011.07.1092] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
50 Li M, Guo T, Cui R, Feng Y, Bai H, Zhang Z. Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis. Cancer Manag Res 2019;11:4005-21. [PMID: 31190979 DOI: 10.2147/CMAR.S194607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
51 Daghestani MH, Daghestani MH, Daghistani M, Ambreen K, Albalawi FS, AlNeghery LM, Warsy AS. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women. BMC Endocr Disord 2020;20:59. [PMID: 32380991 DOI: 10.1186/s12902-020-0537-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Oakley O, Lin P, Bridges P, Ko C. Animal Models for the Study of Polycystic Ovarian Syndrome. Endocrinol Metab 2011;26:193. [DOI: 10.3803/enm.2011.26.3.193] [Cited by in Crossref: 10] [Article Influence: 0.9] [Reference Citation Analysis]
53 Al Khaduri M, Al Farsi Y, Al Najjar TAA, Gowri V. Hospital-based prevalence of polycystic ovarian syndrome among Omani women. Middle East Fertility Society Journal 2014;19:135-8. [DOI: 10.1016/j.mefs.2013.06.006] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Jafari-Gharabaghlou D, Vaghari-Tabari M, Oghbaei H, Lotz L, Zarezadeh R, Rastgar Rezaei Y, Ranjkesh M, Nouri M, Fattahi A, Nikanfar S, Dittrich R. Role of adipokines in embryo implantation. Endocr Connect 2021;10:R267-78. [PMID: 34559064 DOI: 10.1530/EC-21-0288] [Reference Citation Analysis]
55 Ely BR, Francisco MA, Halliwill JR, Bryan SD, Comrada LN, Larson EA, Brunt VE, Minson CT. Heat therapy reduces sympathetic activity and improves cardiovascular risk profile in women who are obese with polycystic ovary syndrome. Am J Physiol Regul Integr Comp Physiol 2019;317:R630-40. [PMID: 31483156 DOI: 10.1152/ajpregu.00078.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
56 Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect 2017;6:647-58. [PMID: 29042448 DOI: 10.1530/EC-17-0243] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
57 Langmár Z. [Diagnosis and treatment of polycystic ovary syndrome]. Orv Hetil 2010;151:584-6. [PMID: 20332077 DOI: 10.1556/OH.2010.28847] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 O’rourke RW. Endometrial hyperplasia, endometrial cancer, and obesity: convergent mechanisms regulating energy homeostasis and cellular proliferation. Surgery for Obesity and Related Diseases 2014;10:926-8. [DOI: 10.1016/j.soard.2014.03.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 2015;7:745-63. [PMID: 26261426 DOI: 10.2147/IJWH.S70314] [Cited by in Crossref: 70] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
60 Gao T, Wu L, Chang F, Cao G. Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocr J 2016;63:93-100. [PMID: 26607017 DOI: 10.1507/endocrj.EJ15-0318] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
61 Tauqir S, Israr M, Rauf B, Malik MO, Habib SH, Shah FA, Usman M, Raza MA, Shah I, Badshah H, Ehtesham E, Shah M. Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial. Adv Ther 2021;38:3842-56. [PMID: 34047916 DOI: 10.1007/s12325-021-01789-5] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
62 Greenfield AM, Charkoudian N, Alba BK. Influences of ovarian hormones on physiological responses to cold in women. Temperature. [DOI: 10.1080/23328940.2021.1953688] [Reference Citation Analysis]
63 Wang L, Li N, Yao X, Chang G, Zhang D, Heizhati M, Wang M, Luo Q, Kong J. Detection of Secondary Causes and Coexisting Diseases in Hypertensive Patients: OSA and PA Are the Common Causes Associated with Hypertension. Biomed Res Int 2017;2017:8295010. [PMID: 28691036 DOI: 10.1155/2017/8295010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
64 Lambrinoudaki I. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome. Maturitas 2011;68:13-6. [PMID: 20943333 DOI: 10.1016/j.maturitas.2010.09.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
65 Xu P, Shen S, Zhang X, Liang F, Xie G, Yi L, Gao Q, Wang Y. Haplotype analysis of single nucleotide polymorphisms in anti-Müllerian hormone gene in Chinese PCOS women. Arch Gynecol Obstet 2013;288:125-30. [DOI: 10.1007/s00404-013-2734-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
66 Cheong YC, Metwally M, Shreeve N, Sadek K, Farquhar C; Cochrane Gynaecology and Fertility Group. Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd009526] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Qasim A, Turcotte M, de Souza RJ, Samaan MC, Champredon D, Dushoff J, Speakman JR, Meyre D. On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obes Rev 2018;19:121-49. [PMID: 29144594 DOI: 10.1111/obr.12625] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 15.0] [Reference Citation Analysis]
68 Mes-Krowinkel MG, Louwers YV, Mulders AG, de Jong FH, Fauser BC, Laven JS. Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients. Fertil Steril 2014;101:1757-65.e1. [PMID: 24680368 DOI: 10.1016/j.fertnstert.2014.02.039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
69 Restuccia DF, Hynx D, Hemmings BA. Loss of PKBβ/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo. Dis Model Mech 2012;5:403-11. [PMID: 22275470 DOI: 10.1242/dmm.008136] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
70 Charifson MA, Trumble BC. Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder. Evol Med Public Health 2019;2019:50-63. [PMID: 31367382 DOI: 10.1093/emph/eoz011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
71 De Frène V, Vansteelandt S, T'Sjoen G, Gerris J, Somers S, Vercruysse L, De Sutter P. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome. Hum Reprod 2014;29:2333-8. [PMID: 24963163 DOI: 10.1093/humrep/deu154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
72 Li Y, Tan J, Wang Q, Duan C, Hu Y, Huang W. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril 2020;113:197-204. [PMID: 31718828 DOI: 10.1016/j.fertnstert.2019.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
73 Cebeci F, Onsun N, Mert M. Insulin resistance in women with hirsutism. Arch Med Sci. 2012;8:342-346. [PMID: 22662009 DOI: 10.5114/aoms.2012.28563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
74 Lin W, Wen L, Wen J, Xiang G. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:747888. [PMID: 34858330 DOI: 10.3389/fendo.2021.747888] [Reference Citation Analysis]
75 Mobeen H, Afzal N, Kashif M. Polycystic Ovary Syndrome May Be an Autoimmune Disorder. Scientifica (Cairo) 2016;2016:4071735. [PMID: 27274883 DOI: 10.1155/2016/4071735] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
76 Li Y, Lin H, Pan P, Yang D, Zhang Q. Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization. Biores Open Access 2018;7:116-22. [PMID: 30083428 DOI: 10.1089/biores.2017.0040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
77 Shah D, Bansal S. Polycystic ovaries - beyond menopause. Climacteric 2014;17:109-15. [PMID: 23895379 DOI: 10.3109/13697137.2013.828687] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
78 Genazzani AD. Inositol as putative integrative treatment for PCOS. Reproductive BioMedicine Online 2016;33:770-80. [DOI: 10.1016/j.rbmo.2016.08.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
79 Idicula-Thomas S, Gawde U, Bhaye S, Pokar K, Bader GD. Meta-analysis of gene expression profiles of lean and obese PCOS to identify differentially regulated pathways and risk of comorbidities. Comput Struct Biotechnol J 2020;18:1735-45. [PMID: 32695266 DOI: 10.1016/j.csbj.2020.06.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Genazzani AD, Ricchieri F, Lanzoni C. Use of metformin in the treatment of polycystic ovary syndrome. Womens Health (Lond) 2010;6:577-93. [PMID: 20597621 DOI: 10.2217/whe.10.43] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
81 Hinney A, Hebebrand J. Three at one swoop! Obes Facts 2009;2:3-8. [PMID: 20054198 DOI: 10.1159/000200020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
82 Wu CC, Schwartzman ML. The role of 20-HETE in androgen-mediated hypertension. Prostaglandins Other Lipid Mediat. 2011;96:45-53. [PMID: 21722750 DOI: 10.1016/j.prostaglandins.2011.06.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]